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Abstract
u-Toxin is a cholesterol-binding, pore-forming cytolysin of Clostridium perfringens. To detect cell surface cholesterol,
we prepared a u-toxin derivative, BCu by biotinylation of a protease-nicked u-toxin, which has the same binding affinity
for cholesterol as u-toxin without cytolytic activity. Human erythrocytes, V79 cells and human umbilical vein endothelial
 .cells HUVEC , were stained with BCu coupled with FITC-avidin, and then the cells were analyzed by either flow
cytometry or laser confocal microscopy. The fluorescence intensity increased in both intact and briefly fixed cells when
treated with BCu . BCu-treated V79 cells were stained by neither trypan blue nor propidium iodide, indicating that BCu
stained just the outer surface of the plasma membrane of vital cells. Treatment of the cells with digitonin, a cholesterol-
sequestering reagent, decreased the fluorescence intensity to the background level, indicating that BCu staining is specific
for cholesterol. The fluorescence intensity of erythrocytes pre-permeabilized with a small amount of u-toxin increased more
than ten-fold, suggesting higher cholesterol contents in the inner layer of the plasma membrane. When cells were cultured
with cholesterol-depleted medium, the fluorescence intensity stained by BCu decreased remarkably in V79 cells, but did not
change in HUVEC. This indicates that cell surface cholesterol may be provided in different ways with these two cell lines.
These results suggest that BCu can be a useful probe for visualizing cell surface cholesterol and for evaluating the effects of
cellular events on the topology and distribution of cholesterol. q 1997 Elsevier Science B.V.
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1. Introduction
Cholesterol is one of the major constituents of
biological membranes and lipoproteins. It affects the
structure and function of biological membranes
through determining the physico-chemical nature of
membranes such as membrane fluidity. Cholesterol
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also influences the pathology of atherosclerosis and
cholesterol-storage disorders such as type-C Nie-
w xmann-Pick disease 1–3 . Recent and growing evi-
dence suggests a role of cholesterol in the mainte-
nance of integrity and function of membrane mi-
w xcrodomain structures called caveolae 4–8 . In spite
of the importance of cholesterol in membrane physi-
ology and pathology, many questions remain to be
answered concerning its organization and behavior in
plasma membranes and intracellular organelles.
Cholesterol functions as a receptor for thiol-
w x w xactivated cytolysins 9–12 , digitonin 13 and polyene
w xantibiotics, such as filipin and amphotericin B 14,15 .
 .u-Toxin perfringolysin O is one of the thiol-activated
cytolysins produced by Clostridium perfringens. This
group of toxins binds to membrane cholesterol and
causes membrane damage by forming pore-like struc-
w xtures in membranes 9–12 . These toxins are sug-
gested to have the same underlying mechanism for
membrane lysis because of close similarities in their
w xprimary structures 16–20 and other characteristics
w x21 . It has been reported that approximately 1.6
molecules of cholesterol neutralize the activity of one
w xmolecule of a thiol-activated cytolysin 22 , suggest-
ing that one molecule of the cytolysin binds one or
two molecules of cholesterol.
In order to study the mechanism of hemolytic
activity of u-toxin, we have obtained two u-toxin
derivatives, Cu and MCu . Cu is produced by limited
proteolysis of u-toxin with subtilisin Carlsberg and
w xexists as a complex of 38 K and 15 K fragments 23 .
MCu is produced by reductive methylation of Cu
w x24 . Cu and MCu have the same binding affinity to
erythrocyte membranes as u-toxin. They bind to
cholesterol, but not to other membrane constituents
w xincluding cholesterol esters and phospholipids 24,25 .
They have no hemolytic activity at temperatures of
208C or below in the case of Cu , or even at 378C in
w xthe case of MCu 24,25 . Cu and MCu do not form
oligomeric structures on membranes at temperatures
where they do not cause hemolysis as judged by
w xelectron microscopy 24,25 and sucrose density gra-
w xdient analysis 26,27 .
Such modified toxins would be useful for visualiz-
ing cell surface cholesterol without membrane dam-
 .age when used in combination with anti- u-toxin
antibody. In this report we prepared another modified
 .u-toxin, biotinylated Cu BCu , which has similar
characteristics to MCu , as a tool for staining cellular
cholesterol. When coupled with FITC-conjugated
avidin, BCu can stain cholesterol on the outer sur-
face of plasma membranes of erythrocytes and cul-
 .tured adherent cells in a procedure that 1 is easier
 .than that using MCu and 2 requires no antibody. In
this paper, using such a u-toxin derivative as a tool,
we further demonstrate that BCu can be used to
envisage the effects of cellular events on the topology
and distribution of cellular cholesterol.
2. Materials and methods
2.1. Preparation of u-toxin and its deri˝ati˝es
u-Toxin was purified from a culture filtrate of C.
perfringens type A strain PB6K N5, and subtilisin
 .Carlsberg-digested u-toxin Cu and methylated Cu
 . w xMCu were prepared as described previously 23,24 .
Biotinylation of Cu was performed with a biotiny-
 .lation kit RPN 28, Amersham, UK . The reaction
was started by addition of 100 ml of biotinylation
reagent to 1 mg Cu in 1 ml of 50 mM sodium borate
buffer pH 8.6. After 1 h stirring at 258C, the reaction
mixture was applied to a Sephadex G-25 column 9.1
. ml equilibrated with phosphate-buffered saline PBS:
138 mM NaCl, 2.7 mM KCl, 2.1 mM Na HPO and2 4
.1.2 mM KH PO . The column was eluted with PBS2 4
 .and fractions containing biotinylated Cu BCu were
collected and stored at 48C after the addition of 1
mgrml bovine serum albumin BSA, Sigma, St.
.Louis, MO .
Hemolytic activity, hemolysis inhibition activity
and binding specificity of modified toxins were mea-
w xsured as described previously 26 .
2.2. Erythrocytes and cells
Human and sheep blood were mixed with equal
volumes of sterile Alsever solution and stored at 48C.
Erythrocytes were collected by centrifugation 900=
.g, 5 min and washed four times with PBS. Aliquots
of washed erythrocytes were suspended in PBS con-
taining 0.1% glutaraldehyde at a 1% hematocrit and
kept in an ice bath for 15 min. The suspensions were
washed four times with PBS and used as fixed ery-
throcytes.
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V79 cells established from Chinese hamster lung
were obtained from the Japanese Cancer Resources
Bank. The cells were maintained in Eagle’s minimum
essential medium MEM, Nissui Pharmaceutical Co.,
.Tokyo, Japan supplemented with 10% fetal bovine
 .serum FBS, ICN Biomedical, CA . Human umbilical
 .vein endothelial cells HUVEC were prepared and
w xmaintained as described previously 28 . In some
experiments, medium containing 10% fetal bovine
 .lipoprotein-deficient serum LPDS, Sigma was used.
2.3. Fluorescent staining of erythrocytes and cultured
cells with BCu
Washed or fixed erythrocytes were suspended in
 .PBS containing 1 mgrml BSA PBSrBSA or in
PBSrBSA containing 5 mgrml BCu at a hematocrit
of 0.3%. The suspensions were incubated at 258C for
20 min, then washed three times with 10 volumes of
PBS, and resuspended in 40 mgrml fluorescein avidin
 .D Vector Laboratories, Burlingame, CA diluted
with PBSrBSA. After incubation for 20 min at 258C,
erythrocytes were washed with PBS and then ana-
lyzed for FITC fluorescence using an EPICS Elite
 .flow cytometer Coulter Electronics, Hialeah, FL at
a wavelength of 488 nm for excitation and 525 nm
for emission. In some experiments, fixed erythrocytes
were treated with 1.5 ngrml u-toxin for 10 min at
258C, and then stained as described above.
V79 cells or HUVEC seeded in 24-well plates
 .Nunc, Roskilde, Denmark were cultured to semi-
confluence in MEM containing 10% FBS. The
medium was changed to serum-free MEM and cells
were incubated further for 2 h to eliminate the effects
of serum cholesterol. Cells in the 24-well plates were
put on ice and rinsed three times with ice-cold PBS.
Then, 0.5 ml of 0.1% glutaraldehyde in PBS was
added to each well and the plates were kept on ice for
15 min. Fixed cells were washed with PBS four
times, and then incubated with 30 mgrml BCu for
20 min at room temperature. Control cells were
incubated with PBSrBSA. After several washes with
PBS, the cells were treated with 40 mgrml fluores-
cein avidin D for 20 min at room temperature. The
cells were rinsed with PBS, and then the FITC fluo-
rescence was detected with an Olympus microscope
IMT2-RFL. The cells were also analyzed with a
fluorescence image analyzer-equipped confocal laser
cytometer ACAS 570, Meridian Instrument, Oke-
.mos, MI, USA .
To examine the specific binding of BCu to mem-
brane cholesterol, fixed cells were preincubated with
4 mM digitonin Wako Pure Chemical Industries,
.Japan for 10 min at 258C. After the incubation, BCu
was added to the reaction mixture to give the final
concentrations of 5 mgrml for erythrocytes and 30
mgrml for cultured cells. Following procedures for
fluorescent staining were the same as described above.
Total cellular cholesterol was measured using the
w xmethod of Richmond 29 after solubilization with
w xdetergent as described by Gamble et al. 30 .
3. Results
( )3.1. Characterization of biotinylated Cu BCu
Hemolytic activity and hemolysis-inhibition activ-
 .ity of Cu , MCu , and biotinylated Cu BCu are
 .shown in Table 1. Hemolytic activity HD was50
defined as the amount of toxin required to cause 50%
 .lysis of sheep erythrocytes 0.5% suspension, 1 ml
in a 30 min incubation at 378C. Cu caused 50%
hemolysis at a concentration of 0.57 ngrml. How-
ever, no hemolysis was detected with MCu or BCu
at concentrations of 68.8 and 164 mgrml, respec-
tively. In addition, when V79 cells were incubated
with 10 mgrml of BCu for 30 min at room tempera-
ture, the ratio of dead cells stained with trypan blue
was only 1.1%. In contrast, more than 95% of V79
cells incubated with 2.5 ngrml of u-toxin were
stained with trypan blue. Therefore, biotinylation was
as effective as methylation in decreasing hemolytic
activity and cytotoxicity.
Binding activities of toxin derivatives were mea-
sured by their ability to inhibit u-toxin-induced
Table 1
Hemolytic activity and binding activity of u-toxin derivatives
Hemolytic activity Binding activity
 .  .HD ngrml ID ngrml50 50
u 0.29 –
Cu 0.57 36.5
MCu )68 800 25.8
BCu )164000 25.5
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hemolysis. Hemolysis caused by 30 ngrml u-toxin at
108C was inhibited by addition of toxin derivatives to
the reaction mixture. The amounts of the derivatives
required to cause 50% inhibition of u-toxin-induced
 .hemolysis ID are listed in Table 1. The ID value50 50
of BCu was close to those of Cu and MCu , whose
binding affinities to erythrocytes were the same as
that of intact u-toxin, as measured by binding of
125 w xI-labeled toxin derivatives to erythrocytes 24,25 .
For analysis of binding specificity to cholesterol,
lipids extracted from human erythrocytes were devel-
oped on a TLC plate. The plate was incubated with
Fig. 1. Specific binding of BCu to cholesterol. Aliquots of
 .standard lipids lane 1 and chloroformrmethanol extract from
 . human erythrocytes lane 2 were applied on TLC plates Poly-
.gram Sil G; Machery-Nagel, Duren and developed with two
w x  .solvent systems as described previously 25 . A One piece was
soaked in a 3% cupric acetater8% phosphoric acid solution and
 .heated at 1408C for detection of lipids. B The other piece was
treated with 10 mgrml BCu followed by 1r250 diluted anti- u-
.toxin rabbit serum and then 1r500 diluted horseradish peroxi-
 . dase-conjugated anti- rabbit IgG serum Cappel, Organon
.Teknika, Belgium . After washing, the plate was developed with
4-chloro-1-naphthol and hydrogen peroxide. The standard lipids
are indicated as follows: SM, sphingomyelin; PC, phosphatidyl-
choline; PE, phosphatidylethanolamine; Chol, cholesterol; IS,
oleyl alcohol; FFA, oleic acid; TG, triolein; Chol E, cholesterol
oleate.
Fig. 2. Flow cytometric profiles of erythrocytes treated with BCu
and other reagents. Human erythrocytes were treated with BCu
andror other reagents and then with 40 mgrml fluorescein
avidin D and analyzed by EPICS Elite. Control cells were treated
with BSA instead of BCu . Left: light scatter profiles which
indicate particle size. Right: fluorescence intensity profiles of
particles which have the size of intact erythrocyte indicated in the
 .  .range of light scatter profiles. A, B intact erythrocytes; C–F
 .  .  .fixed erythrocytes. A, C control; B, D 5 mgrml BCu ; E 4
 .mM digitonin and 5 mgrml BCu ; F 1.5 ngrml u-toxin treat-
ment before 5 mgrml BCu addition.
BCu , and then immunostaining was carried out using
 .anti- u-toxin serum and peroxidase-conjugated sec-
ond antibody. Only one spot, corresponding to
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 .cholesterol, was detected Fig. 1 . Other lipids such
as phospholipids and neutral lipid standards including
esterified cholesterol were not stained.
These results indicate that the binding affinity and
specificity of BCu to cholesterol is equivalent to that
of u-toxin.
3.2. Staining of erythrocytes with BCu
Since BCu has an ability to bind to cholesterol
and no hemolytic activity, we tried to detect surface-
bound BCu by the fluorescence of FITC-conjugated
avidin. Washed human erythrocytes were incubated
with 5 mgrml BCu followed by 40 mgrml fluores-
cein avidin D. The erythrocyte suspension was ana-
 .lyzed with a flow cytometer EPICS , and fluores-
cence was measured only for particles whose sizes
were the same as intact erythrocytes. As shown in
Fig. 2, the fluorescence intensity of control erythro-
cytes treated with fluorescein avidin D alone stayed
 .at a very low level 0.16 at peak, Fig. 2A , although
the fluorescence intensity of BCu-treated cells was
 .obvious 3.8 at peak, Fig. 2B . The same results were
obtained with erythrocytes fixed with glutaraldehyde:
the peak fluorescence intensity was 0.15 for the
 .control and 3.1 for BCu Fig. 2C and D . In addition,
 .  .Fig. 3. Surface cholesterol staining of V79 cells with BCu . Fluorescence left and phase contrast right observations of V79 cells treated
 .  .  .with or without BCu in BSA-containing buffer and then with fluorescein avidin D. A control; B 30 mgrml BCu ; C 4 mM digitonin
and 30 mgrml BCu . Bars50 mm.
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the treatment of fixed erythrocytes with 4 mM digi-
tonin erased the fluorescence intensity by BCu 0.17
.at peak, Fig. 2E . The decrease in fluorescence by the
addition of digitonin, a cholesterol-sequestering agent,
indicates that BCu binding to erythrocytes is specific
for cholesterol.
This fluorescence by BCu seems to originate from
cell surface cholesterol because BCu does not lyse
cellular membranes. In order to confirm this, fixed
erythrocytes were treated with u-toxin at a low con-
 .centration 1.5 ngrml before staining with BCu and
fluorescein avidin D. The peak of fluorescence inten-
 .sity of u-toxin-treated erythrocytes was 83 Fig. 2F ,
over 20 times greater than that of BCu-treated ery-
throcytes. This increase in fluorescence intensity
seems to be due to the increase in the amount of BCu
that could pass through the plasma membrane pores
w xmade with u-toxin oligomers 11,26,27 and then
bind to cholesterol in the inner leaflet.
3.3. Staining of adherent cells with BCu
As the surface cholesterol of erythrocytes was
stained with BCu , we next tried to stain cultured
adherent cells. V79 cells fixed with glutaraldehyde
were treated with 30 mgrml BCu , and then 40
mgrml fluorescein avidin D. Control cells treated
with fluorescein avidin D alone were not stained. The
BCu-treated cells were clearly stained and the fluo-
rescence was abrogated by the addition of digitonin
 .Fig. 3 . To investigate cellular membrane damage,
BCu-treated cells were incubated with 5 mgrml pro-
pidium iodide for more than 20 min. Almost none of
the cells stained with BCu had stained nuclei; the
Fig. 4. Decrease in fluorescence intensity of V79 cells cultured in lipoprotein-deficient serum. Fluorescence observations of V79 cells A,
.  .  .B and HUVEC C, D treated with BCu in BSA-containing buffer and then with fluorescein avidin D. A, C Cells cultured in MEM
 .containing 10% FBS. B, D Cells cultured in MEM containing 10% LPDS. Bars50 mm.
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exceptions were a few dead cells which were detach-
 .ing from the wells data not shown . These results
indicate that BCu can detect cell surface cholesterol
without cellular membrane injury. Other cells, such
as PC12, 3T3, WI-38 and HeLa cells, were also
 .stained with BCu data not shown .
3.4. Effects of cholesterol turno˝er perturbation on
cholesterol staining with BCu
When V79 cells were cultured in the medium with
 .10% lipoprotein-deficient serum LPDS for 24 h,
total cellular cholesterol decreased to 1.31 mgr106
cells, which is 65% of the level in the control cells
 6 .2.02 mgr10 cells cultured in the medium with
10% FBS. At the same time, cell surface cholesterol
 .was detected by BCu-derived fluorescence Fig. 4 .
The fluorescence intensity of V79 cells cultured in
LPDS medium decreased to 15.18"2.35% of that in
the control cells. In contrast, HUVEC cultured with
LPDS had the same fluorescence intensity as the
control cells. The fluorescence intensity of HUVEC
was calculated by the ACAS 570 equipped with a
computer. The intensities were 10.7 " 1.22 =
106rcell for the control and 9.66"0.63=106rcell
 .for LPDS Fig. 5 . However, the treatment of HU-
Fig. 5. Decrease in fluorescence intensity by treatment with
simvastatin. HUVEC were cultured in MEM containing 10%
FBS or 10% LPDS for 2 days and then the medium was replaced
with medium containing simvastatin at the indicated concentra-
tions. After 2 days culture in the presence of simvastatin, cells
were stained with BCu and fluorescein avidin D and analyzed as
described in Section 2.
VEC with normal medium containing 1000 ngrml of
simvastatin, an HMG-CoA reductase inhibitor, caused
a decrease in the fluorescence intensity to 42% of
that in the control cells. Moreover, when simvastatin
was added to the LPDS medium, the fluorescence
intensity was reduced in a dose-dependent manner
 .Fig. 5 . Addition of 100 ngrml simvastatin to HU-
VEC cultured with LPDS medium reduced the fluo-
rescence intensity to less than 10% of that in the
control culture. Although we were unable to obtain a
sufficiently large number of HUVEC for analysis of
cellular cholesterol contents, these results suggest that
de novo cholesterol synthesis is induced in HUVEC
cultured with LPDS, and that inhibition of cholesterol
synthesis with simvastatin diminishes cell surface
cholesterol.
4. Discussion
Thiol-activated cytolysins specifically bind to
membrane cholesterol resulting in membrane lysis.
w xAlthough Pendleton et al. 31 attempted to analyze
cholesterol distribution in membrane with some
thiol-activated cytolysins streptolysin O and cere-
.olysin and their ferritin-labeled antibody, the native
localization of cholesterol was not clear because of
the cytolytic activity of the cytolysins. Using u-toxin
derivatives, cell surface cholesterol can be stained
without membrane damage. We successfully stained
 .cells using MCu , anti- u-toxin antiserum and FITC-
 .conjugated second antibody data not shown . How-
ever, BCu makes the procedure much easier and
 .requires no anti- u-toxin antibody to give similar
results.
In the flow cytometric analysis of erythrocytes,
both intact cells and cells fixed with 0.1% glutaralde-
hyde were well stained with BCu at the same inten-
sity. These results suggest that BCu binding did not
cause membrane lysis even in intact cells, and that
the fixing condition was mild enough for BCu to
bind to cell surface cholesterol as well as it did in
intact cells. In contrast, digitonin and filipin are
difficult to use without membrane damage. Digitonin
and polyene antibiotics such as filipin form specific
complexes with 3-b-hydroxy sterols which can be
w xdetected by electron microscopy 32,33 . The subcel-
lular distribution of cholesterol was detected with a
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 y5 .relatively low dose 10 M of filipin by fluores-
w xcence microscopy using ultraviolet excitation 34 .
Although these methods are useful for analyzing
cholesterol distribution in fixed cells, they are hardly
applicable to viable cells. Since BCu binds cell
surface cholesterol at a low concentration 30 mgrml;
y7 .10 M without membrane impairment, BCu serves
as a more useful probe for the analysis of cell surface
cholesterol.
To examine the applicability of BCu in delineat-
ing the cholesterol topology, fixed erythrocytes were
treated with a small amount of u-toxin and then
stained with BCu . u-Toxin was used to form large
w xpores on the membrane 10,11 so that BCu could get
inside the cells. As the dose of u-toxin used in this
 .experiment 1.5 ngrml, 1r3000 of BCu was very
small, BCu binding was not practically affected.
After the treatment, the fluorescence intensity in-
 .creased more than 10-fold Fig. 2F . Thus, in u-
toxin-treated cells, BCu can bind cholesterol located
on both the outer and inner leaflets of the membrane
bilayer. The result shown in Fig. 2F indicates that the
amount of BCu bound to cholesterol in the inner
leaflet is greater than that bound to cholesterol in the
outer surface of the cell membrane. One explanation
is that the majority of cholesterol might exist in the
inner leaflet of erythrocyte membrane. The asymmet-
ric distribution of phospholipids in the plasma mem-
w xbrane is well known 35,36 , and an asymmetric
distribution of cholesterol was also reported in ery-
w x w x w xthrocytes 37,38 , fibroblasts 39 , tumor cells 40
w xand synaptic plasma membranes 41 . In these re-
ports, the cholesterol content of the inner leaflet was
in the range of 75–88%, which means that only
1r4–1r10 of the total cholesterol exists on the cell
surface. Our observation is consistent with the re-
ported results.
In the second experiment, we employed BCu
staining for elucidating cholesterol metabolism in the
cultured adherent cells. We have shown that total
cellular cholesterol decreased to 65% of the control
in V79 cells cultured with LPDS medium. This result
suggests that in V79 cells, de novo synthesis of
cholesterol does not efficiently occur under lipopro-
tein-deficient conditions. It should be noted that the
fluorescence intensity of LPDS-treated V79 cells de-
creased to less than 20% of the control cells Fig. 4A
.and B , suggesting that cholesterol in the cell surface
is mainly supplied by extracellular lipoproteins. This
remarkable decrease in fluorescence intensity might
also imply that the decrease in cellular cholesterol
primarily affects the cholesterol located in the outer
leaflet of the plasma membrane.
Another type of cell, HUVEC gave a different
result when treated with LPDS. The fluorescence
intensity of LPDS-treated HUVEC was apparently
 .the same as that of control cells Fig. 4C and D .
However, when simvastatin, an HMG-CoA reductase
inhibitor, was added to the LPDS medium, the fluo-
rescence intensity of HUVEC decreased dramatically
 .and dose dependently Fig. 5 , indicating that the
main origin of the cholesterol in the cell surface was
de novo synthesis in LPDS medium. On the other
hand, treatment of HUVEC with simvastatin in FBS
medium decreased the fluorescence intensity to about
42% of that in the control cells, suggesting that cell
surface cholesterol supplied from serum lipoproteins
as well. These results suggest that the origin of cell
surface cholesterol is different among cell lines. BCu
seems to be a useful tool for analyzing cellular
cholesterol metabolism.
Recent evidence in literature indicates that choles-
terol affects the organization and function of gly-
 .cophosphatidyl inositol GPI -anchored proteins and
caveolae, which are non clathrin-coated pits. It has
been reported that the clustered organization of the
folate receptor, a GPI-anchored protein, and the in-
tegrity of caveolae are disrupted when MA104 cells
are deprived of cholesterol by addition of
cholesterol-sequestering agents, such as filipin and
w xnystatin 6,42 . Metabolical deprivation of cholesterol
also affects the clustered organization and transport
w xfunction of the folate receptor 7 . Cholesterol has
been reported to regulate the cell surface expression
w xof GPI-anchored CD14 on human monocytes 43 .
The cholesterol-staining method described here seems
to be useful for analyzing the cholesterol dynamics in
membranes. In fact, we have demonstrated that
FITC-labels concentrate to caveola-rich areas during
the incubation of living keratinocytes treated with
w xBCu 44,45 .
In the present study, a new probe BCu was suc-
cessfully employed to analyze membrane cholesterol
distribution and dynamic changes when the choles-
terol metabolism was modulated. This probe would
have further potential if applied to other detection
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systems using enzyme-, ferritin- or gold-conjugated
avidin.
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